154 related articles for article (PubMed ID: 25268149)
1. Epirubicin loading in poly(butyl cyanoacrylate) nanoparticles manifests via altered intracellular localization and cellular response in cervical carcinoma (HeLa) cells.
Evangelatov A; Skrobanska R; Mladenov N; Petkova M; Yordanov G; Pankov R
Drug Deliv; 2016 Sep; 23(7):2235-2244. PubMed ID: 25268149
[TBL] [Abstract][Full Text] [Related]
2. Epirubicin loaded to pre-polymerized poly(butyl cyanoacrylate) nanoparticles: preparation and in vitro evaluation in human lung adenocarcinoma cells.
Yordanov G; Evangelatov A; Skrobanska R
Colloids Surf B Biointerfaces; 2013 Jul; 107():115-23. PubMed ID: 23466549
[TBL] [Abstract][Full Text] [Related]
3. Entrapment of epirubicin in poly(butyl cyanoacrylate) colloidal nanospheres by nanoprecipitation: formulation development and in vitro studies on cancer cell lines.
Yordanov G; Skrobanska R; Evangelatov A
Colloids Surf B Biointerfaces; 2012 Apr; 92():98-105. PubMed ID: 22154011
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo evaluation of 10-hydroxycamptothecin-loaded poly (n-butyl cyanoacrylate) nanoparticles prepared by miniemulsion polymerization.
Jin X; Asghar S; Zhu X; Chen Z; Tian C; Yin L; Ping Q; Xiao Y
Colloids Surf B Biointerfaces; 2018 Feb; 162():25-34. PubMed ID: 29145001
[TBL] [Abstract][Full Text] [Related]
5. Enhanced oral bioavailability of 10-hydroxycamptothecin through the use of poly (n-butyl cyanoacrylate) nanospheres.
Jin X; Asghar S; Zhu X; Chen Z; Liu J; Li Y; Li H; Ping Q; Xiao Y
Drug Dev Ind Pharm; 2017 Oct; 43(10):1637-1647. PubMed ID: 28481657
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronic acid coated poly(butyl cyanoacrylate) nanoparticles as anticancer drug carriers.
He M; Zhao Z; Yin L; Tang C; Yin C
Int J Pharm; 2009 May; 373(1-2):165-73. PubMed ID: 19429302
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-loaded poly(n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancer.
Ren F; Chen R; Wang Y; Sun Y; Jiang Y; Li G
Pharm Res; 2011 Apr; 28(4):897-906. PubMed ID: 21184150
[TBL] [Abstract][Full Text] [Related]
8. Self-assembled nanoparticles of cholesterol-conjugated carboxymethyl curdlan as a novel carrier of epirubicin.
Li L; Gao FP; Tang HB; Bai YG; Li RF; Li XM; Liu LR; Wang YS; Zhang QQ
Nanotechnology; 2010 Jul; 21(26):265601. PubMed ID: 20522924
[TBL] [Abstract][Full Text] [Related]
9. ApoE3 mediated polymeric nanoparticles containing curcumin: apoptosis induced in vitro anticancer activity against neuroblastoma cells.
Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR
Int J Pharm; 2012 Nov; 437(1-2):29-41. PubMed ID: 22890189
[TBL] [Abstract][Full Text] [Related]
10. ApoE3 mediated poly(butyl) cyanoacrylate nanoparticles containing curcumin: study of enhanced activity of curcumin against beta amyloid induced cytotoxicity using in vitro cell culture model.
Mulik RS; Mönkkönen J; Juvonen RO; Mahadik KR; Paradkar AR
Mol Pharm; 2010 Jun; 7(3):815-25. PubMed ID: 20230014
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in vitro/in vivo anti-cancer evaluation of curcumin-loaded chitosan/poly(butyl cyanoacrylate) nanoparticles.
Duan J; Zhang Y; Han S; Chen Y; Li B; Liao M; Chen W; Deng X; Zhao J; Huang B
Int J Pharm; 2010 Nov; 400(1-2):211-20. PubMed ID: 20813175
[TBL] [Abstract][Full Text] [Related]
12. Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells.
Hanafi-Bojd MY; Jaafari MR; Ramezanian N; Xue M; Amin M; Shahtahmassebi N; Malaekeh-Nikouei B
Eur J Pharm Biopharm; 2015 Jan; 89():248-58. PubMed ID: 25511563
[TBL] [Abstract][Full Text] [Related]
13. Effects of phospholipid and polyethylene glycol monostearate (100) on the in vitro and in vivo physico-chemical characterization of poly(n-butyl cyanoacrylate) nanoparticles.
Jin X; Asghar S; Zhang M; Chen Z; Zhang J; Ping Q; Xiao Y
Colloids Surf B Biointerfaces; 2019 Jan; 173():320-326. PubMed ID: 30312943
[TBL] [Abstract][Full Text] [Related]
14. [Preparation and in vitro release characteristics of vincristine sulphate loaded poly (butylcyanoacrylate) nanoparticles].
Tan R; Liu Y; Feng N; Zhao J
Zhongguo Zhong Yao Za Zhi; 2011 Jun; 36(11):1431-5. PubMed ID: 22779171
[TBL] [Abstract][Full Text] [Related]
15. Cellular uptake and intracellular degradation of poly(alkyl cyanoacrylate) nanoparticles.
Sulheim E; Baghirov H; von Haartman E; Bøe A; Åslund AK; Mørch Y; Davies Cde L
J Nanobiotechnology; 2016 Jan; 14():1. PubMed ID: 26743777
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of poly (butyl) cyanoacrylate nanoparticles containing vasoactive intestinal peptide against 6-hydroxydopamine-induced neurotoxicity in vitro.
Xu ZR; Wang WF; Liang XF; Liu ZH; Liu Y; Lin L; Zhu X
J Mol Neurosci; 2015 Apr; 55(4):854-64. PubMed ID: 25326789
[TBL] [Abstract][Full Text] [Related]
17. Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro.
Lo YL; Wang W
Chem Biol Interact; 2013 Oct; 205(3):188-97. PubMed ID: 23867903
[TBL] [Abstract][Full Text] [Related]
18. Optimization of epirubicin nanoparticles using experimental design for enhanced intravesical drug delivery.
Chang LC; Wu SC; Tsai JW; Yu TJ; Tsai TR
Int J Pharm; 2009 Jul; 376(1-2):195-203. PubMed ID: 19439169
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxicity and apoptotic gene expression in an in vitro model of the blood-brain barrier following exposure to poly(butylcyanoacrylate) nanoparticles.
Hall AM; Hemmer R; Spaulding R; Wetzel HN; Curcio J; Sabel BA; Henrich-Noack P; Pixley S; Hopkins T; Boyce RL; Schultheis PJ; Haik KL
J Drug Target; 2016 Aug; 24(7):635-44. PubMed ID: 26707984
[TBL] [Abstract][Full Text] [Related]
20. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
Li C; Ge X; Wang L
Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
